BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001500:BCG Vaccine; D006801:Humans; D007167:Immunotherapy; D007939:Leukemia L1210 / Q000628:therapy; D007942:Leukemia, Experimental / Q000209:etiology / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D051379:Mice; D008806:Mice, Inbred AKR; D008875:Middle Aged; D009163:Mycobacterium bovis / Q000276:immunology*; D009368:Neoplasm Transplantation; D011925:Rauscher Virus; D012075:Remission, Spontaneous; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous
D001500:BCG Vaccine